Inxight Drugs

Showing 1 - 10 of 22 results

Status:

US Approved Rx (2019)

First approved in 2019

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Conditions:

Istradefylline is a first-in-class adenosine A2A receptor antagonist antiparkinsonian agent and has been marketed as the brand name NOURIAST® in Japan since May 30, 2013. NOURIAST is indicated for the improvement of wearing-off phenomena in patients ...

DIENOGEST

MORE DETAILS

46M3EV8HHE

Status:

US Approved Rx (2017)

First approved in 2010

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Conditions:

Dienogest (Natazia) is a hybrid progestogen that combines properties of both the 19-nortestosterone derivatives and the progesterone derivatives. It is indicated for use by women to prevent pregnancy and for the treatment of heavy menstrual bleeding ...

CARGLUMIC ACID

MORE DETAILS

5L0HB4V1EW

Status:

US Approved Rx (2021)

First approved in 2010

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Conditions:

Carglumic acid is a Carbamoyl Phosphate Synthetase 1 (CPS 1) allosteric modulator. CPS1 is found in the mitochondria and is the first enzyme of the urea cycle, which converts ammonia into urea. Carglumic acid acts as a replacement for NAG in NAGS def...

ELETRIPTAN

MORE DETAILS

22QOO9B8KI

Status:

US Approved Rx (2017)

First approved in 2002

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Conditions:

Eletriptan (eletriptan hydrobromide, trade name Relpax) is a selective 5-hydroxytryptamine (5-HT1B/1D) serotonin receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults. Eletriptan binds with high affin...

FUROSEMIDE

MORE DETAILS

7LXU5N7ZO5

Status:

US Approved Rx (1982)

First approved in 1966

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Conditions:

Furosemide, a sulfonamide-type loop diuretic structurally related to bumetanide, is used to manage hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide inhibits wa...

METHOXSALEN

MORE DETAILS

U4VJ29L7BQ

Status:

US Approved Rx (2014)

First approved in 1954

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Conditions:

Methoxsalen — also called xanthotoxin, marketed under the trade names Oxsoralen, Deltasoralen, Meladinine — is a drug used to treat psoriasis, eczema, vitiligo, and some cutaneous lymphomas in conjunction with exposing the skin to UVA light from lamp...

s or sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, allegedly clearing up the disease. The dosage comes in 10 mg tablets, which are taken in the amount of 30 mg 75 minutes before a PUVA (psoralen + UVA) light treatment. Chemically, methoxsalen belongs to a class of organic natural molecules known as furanocoumarins. They consist of coumarin annulated with furan. It can also be injected and used topically. The exact mechanism of action of methoxsalen with the epidermal melanocytes and keratinocytes is not known. The best known biochemical reaction of methoxsalen is with DNA. Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (crosslinking of psoralen to both strands of DNA) Reactions with proteins have also been described. Methoxsalen acts as a photosensitizer. Administration of the drug and subsequent exposure to UVA can lead to cell injury. Orally administered methoxsalen reaches the skin via the blood and UVA penetrates well into the skin. If sufficient cell injury occurs in the skin, an inflammatory reaction occurs. The most obvious manifestation of this reaction is delayed erythema, which may not begin for several hours and peaks at 48–72 hours. The inflammation is followed, over several days to weeks, by repair which is manifested by increased melanization of the epidermis and thickening of the stratum corneum. The mechanisms of therapy are not known. In the treatment of vitiligo, it has been suggested that melanocytes in the hair follicle are stimulated to move up the follicle and to repopulate the epidermis. In the treatment of psoriasis, the mechanism is most often assumed to be DNA photodamage and resulting decrease in cell proliferation but other vascular, leukocyte, or cell regulatory mechanisms may also be playing some role. Psoriasis is a hyperproliferative disorder and other agents known to be therapeutic for psoriasis are known to inhibit DNA synthesis. The most commonly reported side effect of methoxsalen alone is nausea, which occurs with approximately 10% of all patients. This effect may be minimized or avoided by instructing the patient to take methoxsalen with milk or food, or to divide the dose into two portions, taken approximately one-half hour apart. Other effects include nervousness, insomnia, and psychological depression.

OXOLINIC ACID

MORE DETAILS

L0A22B22FT

Status:

US Previously Marketed

First approved in 1975

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Conditions:

Oxolinic acid is a synthetic quinolone antibiotic related to nalidixic acid. It is authorized in veterinary medicine for use in finfish, calves, pigs, and poultry. It acts by inhibiting bacterial type II topoisomerase activity. Oxolinic acid has been...

NOSCAPINE

MORE DETAILS

8V32U4AOQU

Status:

US Previously Marketed

First marketed in 1897

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Conditions:

Noscapine (also known as Narcotine, Nectodon, Nospen, Anarcotine and (archaic) Opiane) is a benzylisoquinoline alkaloid from plants of the poppy family, without painkilling properties. This agent is primarily used for its antitussive (cough-suppressi...